23andMe Launches New Genetic Reports on Common Forms of Cancer
The reports are based on statistical models known as polygenic risk scores (PRS), developed by 23andMe through its proprietary research database.
- The reports are based on statistical models known as polygenic risk scores (PRS), developed by 23andMe through its proprietary research database.
- Availability of the breast cancer and prostate cancer PRS reports is based on self-reported birth sex.
- The PRS models on which the new 23andMe reports are based were developed using the 23andMe database, and further validated using an external database.
- To learn more about the new 23andMe PRS reports on cancer, and becoming a 23andMe+ Premium member, visit https://www.23andme.com/membership/ .